Mazdutide UAE | Buy Research-Grade Mazdutide | ≥99% Purity

Mazdutide is a dual GLP-1/glucagon receptor co-agonist peptide studied in metabolic research for its combined influence on glucose regulation, energy expenditure, and lipid metabolism — representing one of the most advanced dual-receptor metabolic peptides currently being examined in obesity and metabolic syndrome research. Researchers and institutions across the UAE, Dubai, Abu Dhabi and the wider GCC can source verified, research-grade Mazdutide with fast international dispatch and full batch documentation included.

✅ ≥99% Purity — HPLC Verified

✅ Batch-Specific Certificate of Analysis (CoA) Included

✅ Lyophilised Powder | GMP Manufactured

✅ Fast International Dispatch to UAE & GCC

What is Mazdutide?

Mazdutide (also known by its research designation IBI362) is a synthetic peptide developed as a dual agonist targeting both GLP-1 (glucagon-like peptide-1) receptors and glucagon receptors simultaneously. While GLP-1 receptor agonists like Semaglutide have become well-established tools in metabolic research, Mazdutide adds a second mechanism by also engaging glucagon receptors — which play a distinct but complementary role in energy expenditure, hepatic glucose production, and fat metabolism.

This dual-receptor approach has generated significant research interest because the two pathways — GLP-1 and glucagon — operate through different but interconnected metabolic mechanisms, and studying their simultaneous activation allows researchers to examine metabolic outcomes that single-receptor compounds cannot produce alone. Mazdutide is among a newer generation of multi-receptor metabolic peptides attracting growing attention from research institutions globally, including across the UAE and GCC where metabolic health research is an expanding priority.

What Does Mazdutide Do in Research?

In controlled laboratory and pre-clinical research settings, Mazdutide has been studied across several interconnected metabolic pathways:

Dual GLP-1 and Glucagon Receptor Activation: The defining feature of Mazdutide in research is its ability to simultaneously engage both GLP-1 and glucagon receptors. Studies examine how co-activation of these two receptor systems influences metabolic outcomes compared to selective single-receptor agonism — providing insights into the additive or synergistic effects of dual pathway engagement.

Energy Expenditure Research: Glucagon receptor activation is associated with increased energy expenditure in pre-clinical models. Studies incorporating Mazdutide examine how glucagon pathway engagement alongside GLP-1 signalling affects metabolic rate parameters and overall energy balance in experimental settings.

Glucose Metabolism Studies: Research has examined Mazdutide’s influence on insulin secretion dynamics, hepatic glucose output, and postprandial glucose regulation — areas where GLP-1 and glucagon pathways interact in complex and sometimes opposing ways at the cellular level.

Lipid and Hepatic Metabolism: Glucagon receptor signalling plays a role in hepatic lipid regulation. Studies have used Mazdutide to examine how dual receptor activation affects liver fat accumulation, lipid profile markers, and fatty acid oxidation in pre-clinical metabolic models.

Obesity and Body Composition Research: Pre-clinical studies have examined Mazdutide’s effects on body weight, fat mass distribution, and lean mass preservation in animal models of diet-induced obesity — reflecting its relevance to the growing field of multi-receptor metabolic research.

Appetite and Satiety Signalling: Research has explored how combined GLP-1 and glucagon receptor engagement influences appetite-regulating pathways in the central nervous system and peripheral tissues.

All applications listed are research-based only. Mazdutide is not approved for human therapeutic use.

What Do Studies Say About Mazdutide?

Mazdutide has developed a focused and rapidly growing pre-clinical and early clinical research profile:

Pre-clinical studies examining Mazdutide in obesity models have reported greater reductions in body weight and fat mass markers compared to GLP-1 receptor agonism alone, suggesting that the addition of glucagon receptor engagement produces meaningful differences in metabolic outcomes at the experimental level. Research into Mazdutide’s hepatic effects has documented its influence on liver fat accumulation markers in pre-clinical models of non-alcoholic fatty liver disease, reflecting interest in its potential utility as a research tool for studying metabolic liver conditions. Studies examining the mechanistic balance between GLP-1 and glucagon receptor activation have used Mazdutide to explore how the two pathways interact — particularly given that glucagon typically raises blood glucose while GLP-1 lowers it, making the net metabolic outcome of dual activation a significant area of research interest. Energy expenditure studies have reported increases in metabolic rate parameters in animal models treated with Mazdutide, supporting the hypothesis that glucagon receptor co-activation contributes meaningfully to the overall metabolic profile beyond what GLP-1 agonism alone produces. Its positioning within the emerging class of dual and triple receptor metabolic peptides has made Mazdutide an increasingly relevant research compound as the field moves beyond single-receptor approaches.

Mazdutide vs Other Metabolic Research Peptides

Feature	Mazdutide	Semaglutide	Tirzepatide	CagriSema
Receptor Targets	GLP-1 + Glucagon	GLP-1 only	GLP-1 + GIP	GLP-1 + Amylin
Energy Expenditure Focus	High (glucagon)	Moderate	Moderate	Moderate
Hepatic Metabolism	Yes	Limited	Limited	Limited
Research Generation	Newer dual-agonist	Established	Established	Emerging
Research Profile	Growing	Extensive	Extensive	Emerging

Product Specifications

Parameter	Specification
Also Known As	IBI362
Receptor Targets	GLP-1R + Glucagon Receptor (Dual Agonist)
Purity	≥99% (HPLC Verified)
Form	White Lyophilised Powder
Solubility	Sterile water, bacteriostatic water
Storage (powder)	-20°C, protect from light
Storage (reconstituted)	2–8°C, use within 2–4 weeks

Buying Mazdutide in UAE — What’s Included

Every order of Mazdutide dispatched to the UAE and GCC includes:

• Batch-specific Certificate of Analysis (CoA)
• HPLC Chromatogram
• Mass Spectrometry Confirmation
• Sterility & Endotoxin Testing Report
• Reconstitution Protocol
• Technical Research Support

Frequently Asked Questions — Mazdutide UAE

Can I buy Mazdutide in the UAE?

Yes. We supply research-grade Mazdutide with international dispatch to the UAE, Dubai, Abu Dhabi, Sharjah and across the GCC. All orders include full batch documentation and are packaged to maintain peptide integrity throughout transit.

What makes Mazdutide different from Semaglutide in research?

Semaglutide is a selective GLP-1 receptor agonist, while Mazdutide adds glucagon receptor co-activation to the GLP-1 mechanism. This dual-receptor approach is studied because glucagon and GLP-1 pathways have distinct but related roles in energy metabolism — glucagon being associated with increased energy expenditure and hepatic fat regulation, GLP-1 with insulin secretion and appetite signalling. Studying both simultaneously allows researchers to examine metabolic outcomes beyond what single-receptor GLP-1 agonism alone can produce.

What is the significance of glucagon receptor activation in metabolic research?

Glucagon receptor signalling plays a key role in hepatic glucose production, fat oxidation, and energy expenditure regulation. In isolation, glucagon raises blood glucose — which is why its inclusion in a dual-agonist research compound is carefully balanced against GLP-1’s glucose-lowering effects. Mazdutide is used in research to examine how these opposing yet complementary pathways interact when activated simultaneously and what net metabolic outcomes this produces in experimental models.

How does Mazdutide compare to Tirzepatide in research?

Both are dual-receptor metabolic peptides but target different receptor combinations. Tirzepatide combines GLP-1 and GIP receptor agonism, while Mazdutide combines GLP-1 and glucagon receptor agonism. The distinction is significant because GIP and glucagon have different metabolic roles — making Mazdutide and Tirzepatide complementary rather than equivalent research tools for studying multi-receptor metabolic pathways.

What purity is required for Mazdutide research?

A minimum of ≥98% is considered research grade, though ≥99% is strongly preferred for receptor binding assays and sensitive metabolic studies. All our Mazdutide is independently verified to ≥99% purity.

How is Mazdutide reconstituted for laboratory use?

Allow the vial to reach room temperature before opening. Add sterile or bacteriostatic water slowly down the vial wall and swirl gently without shaking. Aliquot and store at -80°C for longer-term use to avoid freeze-thaw degradation.

How quickly is Mazdutide delivered to UAE?

Orders are dispatched promptly via tracked international courier. Delivery to the UAE typically takes 3–5 working days, with packaging designed to maintain peptide stability throughout transit.

Research Disclaimer: Mazdutide is supplied exclusively for legitimate scientific research purposes conducted within licensed laboratory environments. This product is not intended for human consumption, self-administration, or any therapeutic application. It must be handled by qualified researchers in compliance with applicable UAE regulations and institutional ethics guidelines. Handling should only be performed by qualified laboratory professionals in controlled research settings. By purchasing, you confirm that this compound will be used solely for approved in-vitro or pre-clinical research purposes.